中国美容医学2012，Vol.21Issue(5)：801-803,3.
口服普萘洛尔治疗婴幼儿血管瘤的临床研究
Clinical study on the treatment of infantile hemangioma by oral propranolol
摘要
Abstract
Objective To investigate the therapeutic effect of oral propranolol on infantile hemangioma. Methods From January 2009 to June 2011, oral propranolol was given to 11 infants with hemangiomas at 2mg/kg/day,given in 2 divided doses. The duration of the treatment was three months.If hemangioma recurred, the treatment was repeated. The treatment was discontinued at one year old. Results One week after oral propranolol, hemangiomas became paler and softer. Three months after the treatment, hemangiomas shrinked obviously.At one year old, most of hemangiomas regressed with residual telangieciases. Bradycardia and diarrhea were observed in some patients, which disappeared in one week after stopping oral propranol. Conclusion low -dose oral propranold has a good effect on infantile hemangioma.关键词
婴幼儿血管瘤/普萘洛尔Key words
Infantile hemangioma/ Propranold分类
医药卫生引用本文复制引用
陈鑫,袁斯明..口服普萘洛尔治疗婴幼儿血管瘤的临床研究[J].中国美容医学,2012,21(5):801-803,3.基金项目
国家自然科学基金资助项目(批准号:30700874) （批准号:30700874）
